Home World News FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer...

FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations

July 25, 2025

353

FDA also approved the Oncomine Dx Express Test as a companion diagnostic device